| خلاصه مقاله | Background: Atrophy in hippocampal subfields analysis based on MRI is widely used as a powerful biomarker for the diagnosis and management of neurocognitive diseases. However, there is still no clear consensus on the atrophy pattern in Alzheimer's disease (AD) and mild cognitive impairment (MCI). In this cross-sectional study, hippocampal subfield atrophy in AD and MCI patients is extracted and compared with the normal group (NC). in addition, the symmetry of atrophy in the subfields (left and right) is also assessed. Materials and Methods: MRI images used in this study were selected from Alzheimer's database (ADNI). The images of 20 AD, 20 MCI patients; and 20 Normal control (NC) in the age range of 60-65 years were selected and downloaded. The volume of subfields was extracted automatically using Freesurfer version 7.1.0 software; and then normalized to the total intracranial volume. Finally, asymmetry of subfields volumes was also assessed. Analysis of covariance was used to compare the volume of subfields between the three groups (age and gender as covariates). Results: The results showed that the atrophy in the total hippocampus and its subfields in AD was significantly higher than in the NC, as well as in MCI groups. In terms of asymmetry, it was observed that there is a significant difference in the atrophy of the total hippocampus, hippocampal body, fimbria, the CA3 and GC-ML-DG between the AD and NC group as well as MCI group.
Conclusion: Atrophy of hippocampal subfields are useful biomarker in neurocognitive diseases. In this study, it was seen that the atrophy of all subfields and its asymmetry can be used for distinguishing Alzheimer's from MCI. It was seen that the pattern of atrophy in the left hippocampal subfields is more than in the right. |